Panbela Therapeutics, Inc., a biopharmaceutical company incorporated in Delaware and based in Waconia, Minnesota, has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice of securities offering dated December 21, 2023. The filing reveals that Panbela Therapeutics has already sold $2 million worth of securities and has not specified a total offering amount, indicating an indefinite offering size. The securities offered include equity and options, warrants, or other rights to acquire another security. The offering is not being made in connection with a business combination transaction and is expected to last less than one year. The company has claimed an exemption under Rule 506(b) and has not disclosed the issuer size. The filing also lists...Show More

Panbela Therapeutics, Inc., a biopharmaceutical company incorporated in Delaware and based in Waconia, Minnesota, has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice of securities offering dated December 21, 2023. The filing reveals that Panbela Therapeutics has already sold $2 million worth of securities and has not specified a total offering amount, indicating an indefinite offering size. The securities offered include equity and options, warrants, or other rights to acquire another security. The offering is not being made in connection with a business combination transaction and is expected to last less than one year. The company has claimed an exemption under Rule 506(b) and has not disclosed the issuer size. The filing also lists several related persons, including executive officers and directors, and states that no part of the gross proceeds will be used for payments to these individuals. Sales commissions of $120,000 have been paid to Roth Capital Partners, LLC, with no finder's fees reported. The minimum investment accepted from any outside investor is $0 USD. The offering has been made to at least two investors, and the company has not disclosed whether any non-accredited investors have invested.